Multiple sclerosis (MS) is universally found to be more prevalent in women than men. This
has led to extensive studies of differences in the immune system or nervous system between …

Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous
system disorder that is more common in women, with onset often during reproductive years …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Objective To determine the rate of relapse occurrence during pregnancy and postpartum.
Methods In a cross-sectional study using the national multiple sclerosis (MS) registry …

Background: Available data suggest that pregnancy exposure to interferon-beta might result
in lower mean birth weight and preterm birth. Objective: To determine the effect of interferon …

The influence of pregnancy on the course of multiple sclerosis (MS) has long been
controversial; until the end of 1990s, women with MS were discouraged from having children …

Objective: The objective of this study was to develop evidence-based recommendations on
pregnancy management for persons with multiple sclerosis (MS). Background: MS typically …

Objective To review the current evidence regarding pregnancy-related issues in multiple
sclerosis (MS) and to provide recommendations specific for each of them. Research design …

In recent decades, pregnancy-related issues in multiple sclerosis (MS) have received
growing interest. MS is more frequent in women than in men and typically starts during child …

Introduction Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF)
is an oral agent for the treatment of relapsing forms of multiple sclerosis (MS). No formal …